APS(年龄、血小板、二维剪切波弹性成像)评分预测慢性乙型肝炎患者肝细胞癌
本研究纳入654例活检证实的慢性乙型肝炎患者,基于年龄、血小板计数和二维剪切波弹性成像肝硬度构建APS评分, cutoff 60对HCC风险区分最佳(AUC 0.89),优于CU-HCC评分(AUC 0.70,P=0.005),略高于GAG-HCC评分(AUC 0.82,P=0.052)。
要点
- APS评分仅需年龄、血小板计数和2D SWE肝硬度,cutoff 60区分HCC风险最佳(AUC 0.89)。
- APS评分优于CU-HCC评分(AUC 0.70,P=0.005),略高于GAG-HCC评分(AUC 0.82,P=0.052)。
- 在瞬时弹性成像患者中APS评分AUC 0.79,mREACH-B评分AUC 0.82(P=0.05)。
核心结论
- 基于基线2D SWE肝硬度、年龄和血小板计数的APS评分对预测慢性乙型肝炎患者肝细胞癌有价值。
研究设计与样本
- 研究纳入2011年4月至2015年12月活检证实的慢性乙型肝炎并接受超声和2D SWE检查的患者654例(平均年龄37岁,范围30-43岁,男性510例),随访检测HCC;通过Cox比例风险模型参数除以最小参数并简化为整数分值构建评分系统,比较新评分与其他评分的预测性能。
诊断标准与关键数值
- APS评分cutoff 60对HCC风险区分最佳(AUC 0.89);CU-HCC评分AUC 0.70(P=0.005);GAG-HCC评分AUC 0.82(P=0.052);瞬时弹性成像患者中APS评分AUC 0.79 vs mREACH-B评分AUC 0.82(P=0.05)。
临床应用与阅片要点
- APS评分可用于慢性乙型肝炎患者的HCC风险预测,其预测性能在是否接受抗病毒治疗、炎症分级低或高、丙氨酸氨基转移酶正常或升高的患者中均较好(所有P > .05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Two-dimensional (2D) shear-wave elastography (SWE) has been considered to be useful in predicting hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B (CHB). Purpose To develop a risk model using 2D SWE to predict HCC in patients with CHB and to compare its predictive value with that of other models. Materials and Methods Patients with biopsy-proven CHB who underwent US and 2D SWE between April 2011 and December 2015 were enrolled in this study. After 2D SWE and biopsy were performed, the patients received regular follow-up for the detection of HCC. The scoring system was developed by dividing the parameters of the Cox proportional hazards model by the smallest parameter and simplifying the assigned points to integers. The predictive performance of the new score was compared with that of other scores. Results Among the 654 patients (mean age, 37 years; range, 30-43 years; 510 men), 26 developed HCC. The variables of age, platelet count, and liver stiffness measurement at 2D SWE were weighted to develop the so-called APS score, with a cutoff of 60 showing the best discrimination for HCC risk. The APS score (area under the receiver operating characteristic curve [AUC], 0.89) was superior to that of the Chinese University HCC prediction score constructed from age, albumin level, bilirubin level, hepatitis B virus (HBV) DNA level, and cirrhosis (AUC, 0.70; P = .005) and slightly higher than that of the guide with age, gender, HBV DNA level, core promoter mutations, and cirrhosis, or GAG-HCC score (AUC, 0.82; P = .052). In patients who underwent transient elastography, the AUC of the APS score was 0.79, compared with 0.82 for the modified risk estimation for HCC in CHB, or mREACH-B, score (P = .05). The APS score performed better in patients regardless of whether antiviral treatment was used, inflammation grade was low or high, or alanine aminotransferase levels were normal or high (all P > .05). Conclusion The APS score based on only the patient's baseline liver stiffness measurement at two-dimensional shear-wave elastography, age, and platelet count is valuable for predicting hepatocellular carcinoma in patients with chronic hepatitis B. © RSNA, 2021 Online supplemental material is available for this article.
引用
- Zhang T, Zhang G, Deng X, et al. APS (Age, Platelets, 2D Shear-Wave Elastography) Score Predicts Hepatocellular Carcinoma in Chronic Hepatitis B. Radiology. 2021. PMID: 34427463. doi:10.1148/radiol.2021204700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。